MAP1LC3A and hepatocellular carcinoma: The expression of LC3 and Beclin-1 were analyzed by immunohistochemistry on tissues from 190 HCC patients, and LC3 expression was a significant independent prognostic factor of overall survival (OS) and predict time to recurrence (TTR).